https://www.siliconvalley.com/2021/12/15/covid-cdc-vaccine-advisers-to-revisit-benefits-and-risks-of-johnson-johnson-vaccine/

(CNN) — The US Centers for Disease Control and Prevention’s vaccine advisers will meet on Thursday to revisit the benefits and risks for the Johnson & Johnson Covid-19 vaccine.

The Advisory Committee on Immunization Practices is scheduled to vote on “updated recommendations for use,” according to an agenda for the meeting posted online Wednesday.